| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 1-6 months |
| Number of Subjects | 17 |
| Sex | Female |
| Age Range | 45-64 |
| Body Types | Overweight, Average |
As assessed by ultrasound, red clover extract (40-80mg isoflavones) appears to increase arterial compliance by up to 23% in otherwise healthy postmenopausal women despite no influence on circulating lipids relative to placebo group (randomization had 5-fold more women in active treatment than placebo, and the sample size was only 17).Funding issues for this study:
(Rating of C given to this study due to the low sample in placebo group and a high dropout rate of 35%)
Supplies provided by Novagen, study not funded by Novagen
